Menopause: Naturopathic Support for Hormones, Sleep, Metabolism and Long-Term Health

What is menopause?

Menopause is reached when you have gone 12 consecutive months without a menstrual period, provided there is no other medical reason for your periods to have stopped.

Technically, menopause refers to the final menstrual period, while the years afterwards are known as postmenopause.

Unlike perimenopause, where oestrogen and progesterone can fluctuate significantly from month to month, after menopause the hormonal environment becomes more consistently low in ovarian oestrogen and progesterone because regular ovulation has stopped.

This is an important distinction.

The transition is no longer primarily about unpredictable hormonal swings. It is about how the body adapts to a different hormonal environment over the longer term.

And because oestrogen receptors are found throughout the body, the effects can extend beyond periods and reproductive health to areas such as temperature regulation, sleep, vaginal and urinary health, bone, muscle, metabolism and the cardiovascular system.

Menopause usually occurs naturally in the early 50s, but it can happen earlier or occur suddenly following surgery or certain medical treatments.

How do you know when you’ve reached menopause?

One of the confusing things about menopause is knowing when perimenopause has actually ended.

If you’re over 45 and not using hormonal contraception, menopause is generally identified after 12 consecutive months without a period. In most women, blood tests are not needed to confirm it.

This is different from perimenopause, when periods may disappear for several months and then unexpectedly return.

Hormone testing can also become difficult to interpret because FSH and oestrogen change considerably during the transition, and hormonal contraception or menopausal hormone therapy (MHT) can make the picture less clear. Current guidelines therefore recommend relying primarily on your symptoms and menstrual history in otherwise healthy women over 45.

There are situations where the approach is different.

If menopause is suspected between 40 and 45, or before 40, FSH testing may be appropriate as part of confirming what is happening. Women who have had a hysterectomy may also need to rely more heavily on their symptom pattern because there is no menstrual cycle to use as a marker.

The important point is that menopause is not usually something you need one particular hormone result to “prove”.

It is the point your menstrual and hormonal pattern has been moving towards throughout the menopausal transition.

What are the symptoms of menopause?

Menopause can affect sleep, temperature regulation, mood, cognition, sexual health, the urinary system, muscles, joints and metabolism.

Symptoms may include:

• • hot flushes and night sweats
  • disrupted sleep
  • brain fog or difficulty concentrating
  • anxiety, irritability or low mood
  • vaginal dryness or burning
  • pain during sex
  • urinary urgency or recurrent urinary tract infections
  • changes in libido
  • headaches
  • joint or muscle aches
  • changes in body composition or weight
  • changes in skin or hair

Not every woman experiences all of these, and some symptoms that begin during perimenopause may continue after the final period.

What changes hormonally after menopause?

After menopause, the hormonal environment becomes much more consistently low in ovarian oestrogen and progesterone.

But what that means can look very different from one woman to another.

Some women are mainly bothered by hot flushes or poor sleep. Others notice vaginal dryness, joint discomfort, changes in body composition or a feeling that their body is ageing differently. And some of the most important effects, such as bone loss, may be happening quietly without causing obvious symptoms at all.

This is why I don’t look at menopause simply as a question of whether oestrogen is “low”.

The more useful question is what that hormonal change is doing in your body, which symptoms fit the picture and what else may be contributing alongside it.

Oestrogen affects far more than your period

One of the biggest shifts after menopause is that oestrogen becomes consistently lower.

Because oestrogen receptors are found throughout the brain, bones, blood vessels, skin, muscles, vagina and urinary tract, the effects can show up in very different ways.

You may notice hot flushes, disrupted sleep, brain fog, vaginal dryness, urinary changes, joint discomfort or changes in body composition.

But lower oestrogen can also affect areas you cannot necessarily feel.

Bone is a good example. Oestrogen plays an important role in maintaining bone density, and the decline around menopause can accelerate bone loss. Over time, this can increase the risk of osteopenia and osteoporosis, often without any obvious warning signs.

Muscle mass and strength can also become more important, particularly as ageing, activity levels, nutrition and hormonal changes begin interacting with one another.

So the symptom you notice first is not always the only thing that matters.

A woman coming in because of hot flushes may also need us to think about bone health, muscle, metabolic health or vaginal and urinary changes that have not yet become her main concern.

Progesterone is no longer produced cyclically

Progesterone is mainly produced after ovulation.

Once regular ovulation has stopped, the normal monthly rise in progesterone that used to occur after ovulation disappears too. This is an expected part of menopause rather than a sign that the body has “failed” to make enough progesterone.

Micronised progesterone can still have an important role in menopausal hormone therapy, particularly when systemic oestrogen is prescribed to a woman who still has her uterus.

But that is different from trying to recreate a normal menstrual cycle.

This distinction matters because I don’t think of menopause as simply replacing every hormone that now measures lower.

The question is which hormones, if any, are appropriate for your symptoms, medical history and stage of life.

What happens to testosterone after menopause?

After menopause, some women notice changes in libido, sexual response, energy or muscle strength and wonder whether low testosterone is part of the picture.

Sometimes it may be relevant, but these symptoms are not specific to testosterone.

Libido, for example, can be affected by vaginal dryness or pain during sex, poor sleep, mood, medication, stress, relationship factors and the wider hormonal changes of menopause.

This is why I don’t look at testosterone in isolation.

Testosterone can have a role for some women with persistent, distressing low libido, particularly when other contributing factors have been considered. But it is not routinely recommended as a treatment for fatigue, weight gain or general wellbeing.

The more useful question is not simply, “Is my testosterone low?”

It is whether testosterone is actually relevant to the symptoms you are experiencing and whether it is appropriate in the context of your broader hormone and health picture.

Vaginal dryness, urinary symptoms and genitourinary syndrome of menopause

Vaginal and urinary changes are some of the most common symptoms after menopause, but they are also some of the least talked about.

You may notice dryness, burning, irritation, pain during sex, urinary urgency, needing to urinate more often or recurrent urinary tract infections. Sometimes these changes creep in gradually, and it can be easy to assume they are simply part of getting older.

But there is a physiological reason they happen.

Lower oestrogen affects the tissues of the vagina, vulva, urethra and bladder. These tissues can become thinner, drier and less elastic, while changes in the vaginal environment can also affect the protective microbial balance. Collectively, these changes are known as genitourinary syndrome of menopause, or GSM.

Unlike hot flushes, which may improve over time, vaginal and urinary symptoms can persist or become more noticeable if they are not addressed.

But low oestrogen isn’t the only possible explanation.

Burning, pain, urinary urgency or recurrent infections can also overlap with pelvic floor dysfunction, vulval skin conditions, changes in the vaginal microbiome or other urinary and gynaecological conditions.

This is why I don’t assume that every new vaginal or urinary symptom after menopause is simply “low oestrogen”.

The symptom is a clue. Understanding what is actually contributing to it is what determines what needs attention next.

Menopause, sleep and why you may start waking at 3am

Sleep can change significantly after menopause, and it doesn’t always look like difficulty falling asleep.

You may fall asleep easily but start waking several times through the night, wake at 3am feeling suddenly alert, or find that your sleep has become much lighter than it used to be.

Sometimes hot flushes or night sweats are the obvious reason. But not always.

Lower oestrogen can influence sleep regulation, while changes in mood, stress-response signalling and the normal shifts that occur with ageing can make sleep more fragile. At the same time, other issues such as sleep apnoea, restless legs, medication, thyroid dysfunction or iron deficiency can create a very similar pattern.

This is why I don’t automatically assume every 3am wake up after menopause is simply a hormone problem. I want to know what is actually waking you.

Are you hot? Anxious? Needing to urinate? Snoring? Restless? Or simply awake for no obvious reason? There is a long list of things that can wake you up.

Those details matter because the same symptom can point to very different causes.

Understanding the pattern is what helps determine whether hormones are part of the picture, or whether something else also needs attention.

Menopause, weight and metabolic changes

For some women, one of the most frustrating changes after menopause is that their body seems to respond differently even when their habits have not changed very much.

You may notice weight settling more around the abdomen, losing weight becoming harder, or feeling as though the strategies that worked for you in your 30s and 40s no longer have the same effect.

This is not simply a matter of willpower.

Lower oestrogen can influence where fat is stored, insulin sensitivity and the way the body maintains muscle. At the same time, ageing, activity levels, sleep, stress, alcohol intake and nutrition all affect metabolic health too.

Muscle is an important part of this picture.

As muscle mass gradually declines with age, the body can become less efficient at handling glucose and maintaining strength. Menopause can add another layer to that change, particularly if sleep is poor, activity has reduced or protein intake is not keeping pace with what the body needs.

This is why I don’t assume that weight gain after menopause means you simply need to eat less.

I want to understand what has actually changed. Is there a shift in body composition? Has insulin sensitivity changed? Are you losing muscle? Has sleep deteriorated? Are thyroid function, medication or other metabolic factors contributing?

The number on the scales is only one piece of information.

Understanding what has changed underneath it is much more useful than simply trying harder to make the number go down.

Menopause and bone health

Bone loss is something many women don’t think about until a scan shows osteopenia or osteoporosis.

The difficulty is that bone loss is usually silent.

You don’t necessarily feel it happening, and you can feel completely well while bone density is gradually changing in the background.

Lower oestrogen after menopause accelerates bone breakdown, which is one reason bone health becomes more important at this stage of life. But oestrogen is only one part of the picture.

Family history, body weight, muscle mass, resistance exercise, vitamin D, calcium and protein intake, smoking, alcohol, steroid use and other medical conditions can all influence bone strength over time.

This is why I don’t think of osteoporosis risk as simply a consequence of “low oestrogen”.

I want to know what else may be increasing or reducing that risk, whether bone density has ever been assessed and whether there are clues in your history that make earlier investigation more important.

The goal is not to wait until bone loss becomes a problem.

It is to understand your individual risk early enough to support bone strength as part of your long-term health.

Menopause and cardiovascular health

Heart health is not always the first thing women think about when they reach menopause.

You may be much more focused on hot flushes, poor sleep, weight changes or brain fog, while cholesterol, blood pressure and metabolic health are changing more quietly in the background.

After menopause, lower oestrogen can influence LDL cholesterol, body fat distribution, insulin sensitivity and vascular health. But menopause is only one part of the cardiovascular picture. Age, genetics, blood pressure, smoking, blood sugar regulation, activity, sleep and stress all matter too.

This is why I don’t like looking at one cholesterol result in isolation.

A standard lipid panel gives us useful information, but it does not always capture the whole cardiovascular risk picture. Depending on your history, it may also be useful to look at markers such as ApoB and lipoprotein(a), alongside triglycerides, blood pressure, blood sugar regulation, family history and other relevant risk factors.

Stress physiology can also be part of the picture. Prolonged stress and disrupted cortisol signalling can influence blood pressure, insulin sensitivity, body composition and lipid metabolism. So if cholesterol changes alongside poor sleep, prolonged stress, weight gain or other metabolic changes, I want to understand what else is happening rather than assuming the cholesterol number appeared in isolation.

That does not mean elevated cholesterol should be ignored, or that statins are never appropriate.

For some women, lipid-lowering medication can be an important part of reducing cardiovascular risk. But the decision should ideally be based on the whole clinical picture rather than one number alone.

This is where the detective work matters. I look at whether cholesterol has changed over time and what is happening alongside it – triglycerides, insulin sensitivity, blood pressure, sleep, stress, body composition and family history.

The aim is not simply to make one laboratory value look better.

It is to understand why it has changed, what your overall cardiovascular risk actually looks like and which factors deserve attention.

Menopausal hormone therapy (MHT) after menopause

Menopausal hormone therapy (MHT), often still referred to as hormone replacement therapy (HRT), can be very effective for menopause symptoms, but choosing MHT is not simply about replacing hormones that are now “low”.

The type of hormone, how it is delivered, whether you still have your uterus, your symptoms and your individual medical history all matter.

This is why I look at MHT as part of the wider clinical picture rather than assuming the same combination will suit every woman.

Oestrogen therapy after menopause

Oestrogen therapy can help with symptoms such as hot flushes and night sweats and can also help protect against the accelerated bone loss that occurs after menopause.

Oestradiol can be delivered through the skin using a gel such as Estrogel or an oestrogen patch. This transdermal route avoids first-pass metabolism through the liver and has a more favourable blood clot and stroke risk profile than oral oestrogen, which is one reason I prefer to focus on transdermal oestradiol when discussing MHT.

But oestrogen is not something I think about in isolation.

When Estrogel or an oestrogen patch is used in a woman who still has her uterus, adequate endometrial protection is important. Oestrogen stimulates the lining of the uterus, and using it without adequate protection can increase the risk of endometrial hyperplasia and endometrial cancer.

In my clinical work, the form I am most interested in is micronised progesterone, commonly prescribed as Prometrium. Micronised progesterone is structurally identical to the progesterone naturally produced by the ovaries and can be used alongside Estrogel or an oestrogen patch to protect the endometrial lining.

Vaginal oestrogen vs Estrogel – what is the difference?

Vaginal oestrogen and Estrogel are both forms of oestrogen therapy, but they do very different jobs.

Estrogel is absorbed through the skin into the bloodstream, so it has effects throughout the body and can be used for symptoms such as hot flushes and night sweats.

Vaginal oestrogen works mainly within the vaginal and urinary tissues. It can be particularly useful for vaginal dryness, burning, pain during sex, urinary urgency and other symptoms of genitourinary syndrome of menopause.

Only a minimal amount is absorbed into the bloodstream compared with whole-body oestrogen treatment, so vaginal oestrogen does not usually require micronised progesterone for endometrial protection when it is being used at standard local doses.

This is also why vaginal oestrogen does not replace Estrogel when whole-body menopause symptoms need treatment.

And the reverse is true too. Some women use Estrogel or an oestrogen patch and still experience vaginal or urinary symptoms, in which case vaginal oestrogen can also be used alongside their MHT.

The question is not which one is better.

It is whether you need local treatment, whole-body treatment or sometimes both.

Prometrium orally vs vaginally – does the route matter?

Some women tolerate oral Prometrium very well. Others notice that it makes them feel groggy, dizzy, flat or unusually sedated the next day.

That difference can matter when you are trying to find an MHT approach that is not only effective, but that you can actually tolerate.

Oral Prometrium is processed through the liver, which produces metabolites that can contribute to its sedating effects. Vaginal use changes the way micronised progesterone is absorbed and may feel quite different for some women.

But the two routes are not automatically interchangeable.

When micronised progesterone is being used alongside Estrogel or an oestrogen patch, it has an important job – protecting the lining of the uterus from the stimulating effects of oestrogen.

Vaginal micronised progesterone can be used for endometrial protection in some circumstances, but this use may be off-label and the evidence around the optimal dose and regimen is less established than for oral use.

So the question is not simply whether oral or vaginal Prometrium feels better.

It is finding a route and regimen that you tolerate while still providing the endometrial protection you need.

What if micronised progesterone makes you feel worse?

Some women tolerate micronised progesterone easily. Others notice low mood, irritability, bloating, sedation, dizziness or simply feel unlike themselves while taking it.

This can become particularly important after menopause because micronised progesterone is commonly used alongside Estrogel or an oestrogen patch as part of MHT.

Women with a history of PMS or PMDD may also be particularly sensitive to hormone-related mood changes. PMDD involves an altered response to hormonal fluctuations and progesterone-derived neurosteroids such as allopregnanolone, while oral micronised progesterone is also metabolised into neuroactive compounds that can affect mood and sedation in some women.

That does not mean every woman with a history of PMDD will react badly to Prometrium.

But it does mean your previous response to hormonal changes is worth considering when MHT is being planned.

And when Estrogel or an oestrogen patch is being used, the answer is not simply to stop micronised progesterone if it makes you feel worse.

The route, dose and regimen may need to be reviewed with your prescribing clinician so you can find an approach you tolerate while still protecting the endometrial lining.

What about cancer risk?

Cancer risk is one of the biggest concerns women have about menopausal hormone therapy, but the conversation is often reduced to the question, “Does HRT cause cancer?”

The reality is more nuanced.

Different cancers have different relationships with MHT, and your baseline risk before you ever start treatment matters too.

One of the clearest issues is endometrial protection. Estrogel and oestrogen patches stimulate the lining of the uterus, which is why adequate micronised progesterone is important when endometrial protection is needed. Without it, the risk of endometrial hyperplasia and endometrial cancer increases.

Breast cancer risk is different. Current evidence shows that breast cancer risk varies according to the MHT regimen and duration of use, and increases with combined MHT over time. Importantly, current guidance does not support the claim that using micronised progesterone completely removes that increased breast cancer risk.

Ovarian cancer is another consideration. The absolute increase in risk associated with menopausal hormone therapy is small, but it still needs to be considered alongside your personal and family history.

Genetics can also change the conversation considerably.

Women with inherited cancer-risk variants such as BRCA1 or BRCA2, Lynch syndrome, or a strong family history of breast or ovarian cancer need a more individualised assessment. Having a BRCA1 or BRCA2 variant does not automatically mean MHT can never be used. In women without a previous breast cancer who undergo risk-reducing removal of the ovaries before natural menopause, MHT may still have important health benefits.

This is why I don’t think women should be told either that MHT is “dangerous” or that it is automatically safe.

The more useful question is what your individual risk looked like before MHT, what type of hormone therapy is being considered and whether the benefits and risks make sense for you.

For women with a significant personal or inherited cancer risk, that decision should be made alongside an appropriately experienced menopause or oncology specialist.